X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

RARE

Closed

Ultragenyx

36.26
-0.10 (-0.28%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 36.36
Day's Range: 35.51 - 36.9899
Send
When Written:
 
38.43
Ultragenyx is a biopharmaceutical company that focuses on developing treatments for rare and ultra-rare genetic diseases. The company was founded in 2010 and is headquartered in Novato, California.

Ultragenyx has a diverse pipeline of therapies in various stages of development, targeting diseases such as lysosomal storage disorders, metabolic disorders, and rare genetic diseases. The company has received FDA approval for several drugs, including Crysvita, a treatment for X-linked hypophosphatemia, and Mepsevii, a treatment for mucopolysaccharidosis VII.

In addition to its own research and development efforts, Ultragenyx also partners with other companies and academic institutions to advance rare disease research. The company is committed to improving the lives of patients with rare diseases and has a strong focus on patient advocacy and engagement.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X